USING METABOLOMIC SIGNATURES FOR RISK-STRATIFICATION AND PERSONALIZED TREATMENT OF BLADDER CANCER

$1,531,992FY2021Defense Health AgencyDOD

University Of Maryland, Baltimore

Investigators